ArticleFrontiers in public health2026

Paradox of atropine in myopia control: exploring dose-dependent efficacy, rebound effects, and optimal risk-benefit balance-a perspective.

Ya-Zhen Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.